Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free PBMWW Stock Alerts

Psyence Biomedical (PBMWW) Competitors

$0.03 +0.00 (+12.03%)
As of 11:03 AM Eastern
Compare

PBMWW vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

Should you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

How does Psyence Biomedical compare to Ainos?

Ainos (NASDAQ:AIMDW) and Psyence Biomedical (NASDAQ:PBMWW) are both pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Psyence Biomedical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$124.16KN/AN/AN/AN/A
Psyence BiomedicalN/AN/AN/AN/AN/A

In the previous week, Ainos' average media sentiment score of 0.00 equaled Psyence Biomedical'saverage media sentiment score.

Company Overall Sentiment
Ainos Neutral
Psyence Biomedical Neutral

Summary

Ainos beats Psyence Biomedical on 1 of the 1 factors compared between the two stocks.

How does Psyence Biomedical compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Psyence Biomedical (NASDAQ:PBMWW) are both pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

In the previous week, Alvotech's average media sentiment score of 0.00 equaled Psyence Biomedical'saverage media sentiment score.

Company Overall Sentiment
Alvotech Neutral
Psyence Biomedical Neutral

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Psyence Biomedical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
Psyence BiomedicalN/AN/AN/AN/AN/A

Summary

Alvotech beats Psyence Biomedical on 1 of the 1 factors compared between the two stocks.

How does Psyence Biomedical compare to Aravive?

Aravive (NASDAQ:ARAV) and Psyence Biomedical (NASDAQ:PBMWW) are both pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

In the previous week, Aravive's average media sentiment score of 0.00 equaled Psyence Biomedical'saverage media sentiment score.

Company Overall Sentiment
Aravive Neutral
Psyence Biomedical Neutral

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Psyence Biomedical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Psyence BiomedicalN/AN/AN/AN/AN/A

Summary

Aravive beats Psyence Biomedical on 2 of the 2 factors compared between the two stocks.

How does Psyence Biomedical compare to Atlantic Coastal Acquisition Corp. II?

Psyence Biomedical (NASDAQ:PBMWW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Psyence BiomedicalN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Psyence BiomedicalN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

In the previous week, Psyence Biomedical's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
Psyence Biomedical Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Summary

Psyence Biomedical and Atlantic Coastal Acquisition Corp. II tied by winning 0 of the 0 factors compared between the two stocks.

How does Psyence Biomedical compare to Avidity Biosciences?

Psyence Biomedical (NASDAQ:PBMWW) and Avidity Biosciences (NASDAQ:RNA) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

In the previous week, Avidity Biosciences had 1 more articles in the media than Psyence Biomedical. MarketBeat recorded 1 mentions for Avidity Biosciences and 0 mentions for Psyence Biomedical. Psyence Biomedical's average media sentiment score of 0.00 equaled Avidity Biosciences'average media sentiment score.

Company Overall Sentiment
Psyence Biomedical Neutral
Avidity Biosciences Neutral

Psyence Biomedical has higher earnings, but lower revenue than Avidity Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Psyence BiomedicalN/AN/AN/AN/AN/A
Avidity Biosciences$18.62MN/A-$322.30MN/AN/A

Psyence Biomedical has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Psyence Biomedical's return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Psyence BiomedicalN/A N/A N/A
Avidity Biosciences -3,650.39%-44.92%-39.57%

Avidity Biosciences has a consensus target price of $69.42, indicating a potential upside of 438.57%. Given Avidity Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Avidity Biosciences is more favorable than Psyence Biomedical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Psyence Biomedical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Avidity Biosciences
1 Sell rating(s)
12 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.32

Summary

Avidity Biosciences beats Psyence Biomedical on 6 of the 9 factors compared between the two stocks.

Get Psyence Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for PBMWW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PBMWW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PBMWW vs. The Competition

Export
MetricPsyence BiomedicalPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$906.24M$4.24B$12.08B
Dividend YieldN/A4.84%5.87%5.26%
P/E RatioN/A1.7423.3827.29
Price / SalesN/A119.43159.1276.22
Price / CashN/A20.0752.0853.90
Price / BookN/A7.6138.616.74
Net IncomeN/A-$4.80M$114.66M$332.77M
7 Day PerformanceN/A1.87%3.01%3.99%
1 Month PerformanceN/A6.42%6.18%8.79%
1 Year PerformanceN/A32.03%20.20%43.14%

Psyence Biomedical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PBMWW
Psyence Biomedical
N/A$0.03
+12.0%		N/A+153.3%$0.00N/AN/AN/A
AIMDW
Ainos
N/A$0.11
+24.3%		N/A-65.4%$0.00$124.16KN/A40
ALVOW
Alvotech
N/A$0.28
+29.4%		N/AN/A$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:PBMWW) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners
A U.S. Resource Gap Is a National Issue - and Opportunity
America still does not domestically produce one mineral tied to batteries, energy storage, and national defens...
i2i Marketing Group, LLC | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
Trump and Elon are BACK
15X Bigger Than SpaceX: Elon's New Launch While the rest of the market goes crazy for "the mother of all IP...
InvestorPlace | Sponsoredtc pixel
They’re buying gold before the announcement
The U.S. holds 8,133 tonnes of gold valued at a fraction of today's market price - and one executive order cou...
Reagan Gold Group | Sponsoredtc pixel